Compare LMAT & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | SAM |
|---|---|---|
| Founded | 1983 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2006 | 1996 |
| Metric | LMAT | SAM |
|---|---|---|
| Price | $93.41 | $158.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 11 |
| Target Price | $105.80 | ★ $233.70 |
| AVG Volume (30 Days) | 252.6K | ★ 262.8K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | 30.57 | ★ 95.45 |
| EPS | ★ 0.68 | N/A |
| Revenue | $249,602,000.00 | ★ $1,964,994,000.00 |
| Revenue This Year | $14.21 | $1.02 |
| Revenue Next Year | $8.88 | $1.31 |
| P/E Ratio | $137.59 | ★ N/A |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $79.01 | $158.68 |
| 52 Week High | $118.01 | $264.46 |
| Indicator | LMAT | SAM |
|---|---|---|
| Relative Strength Index (RSI) | 35.69 | 24.80 |
| Support Level | $82.26 | N/A |
| Resistance Level | $114.38 | $228.42 |
| Average True Range (ATR) | 2.99 | 6.69 |
| MACD | -0.41 | -0.57 |
| Stochastic Oscillator | 27.34 | 1.99 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.